ÀÚ·á¸ðÀ½

°¨¿° Áúȯº° °¡À̵å¶óÀÎ

±Û ¸ñ·Ï
  • °áÇÙÁø·áÁöħ 2024 (5ÆÇ)
    °áÇÙ Áø·áÁöħ 2024
    °áÇÙÁø·áÁöħ 2024 (5ÆÇ)

    ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ, Áúº´°ü¸®º»ºÎ

  • ¸¸¼º Äڷγª19 ÁõÈıº(Long COVID) ÀÓ»óÁø·áÁöħ ±Ç°í¾È
    COVID-19 Áø·áÁöħ 2024
    ¸¸¼º Äڷγª19 ÁõÈıº(Long COVID) ÀÓ»óÁø·áÁöħ ±Ç°í¾È

  • Guidelines for Infection Control and  Burnout Prevention in Healthcare Workers Responding to COVID-19
    COVID-19 Áø·áÁöħ 2023
    Guidelines for Infection Control and Burnout Prevention in Healthcare Workers Responding to COVID-19

  • Ç×»ýÁ¦ »ç¿ë°ü¸® ÇÁ·Î±×·¥ÀÇ ±¹³» ½ÇÇàÀ» À§ÇÑ Çٽɿä¼Ò -Á¾ÇÕº´¿ø´ë»ó-
    Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ Áöħ 2023
    Ç×»ýÁ¦ »ç¿ë°ü¸® ÇÁ·Î±×·¥ÀÇ ±¹³» ½ÇÇàÀ» À§ÇÑ Çٽɿä¼Ò -Á¾ÇÕº´¿ø´ë»ó-

    ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ, ´ëÇÑ°¨¿°ÇÐȸ, ´ëÇÑÀÇ·á°ü·Ã°¨¿°°ü¸®ÇÐȸ, ´ëÇѼҾư¨¿°ÇÐȸ, Çѱ¹º´¿ø¾à»çȸ

  • ¸¸¼º Äڷγª19ÁõÈıº(Long COVID) Áø·áÁöħ ¿¹ºñ ±Ç°í¾È
    COVID-19 Áø·áÁöħ 2022
    ¸¸¼º Äڷγª19ÁõÈıº(Long COVID) Áø·áÁöħ ¿¹ºñ ±Ç°í¾È

    ´ëÇÑ°¨¿°ÇÐȸ

  • ¼ºÀÎ º¹°­ ³» °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ
    ¼ÒÈ­±â°è °¨¿° Áø·áÁöħ 2022
    ¼ºÀÎ º¹°­ ³» °¨¿° Ç×»ýÁ¦ »ç¿ëÁöħ

    ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ, ´ëÇÑ°¨¿°ÇÐȸ

  • Äڷγª19 ȯÀÚ Ä¡·á¸¦ À§ÇÑ ÀÓ»óÁø·áÁöħ
    COVID-19 Áø·áÁöħ 2022
    Äڷγª19 ȯÀÚ Ä¡·á¸¦ À§ÇÑ ÀÓ»óÁø·áÁöħ

    Çѱ¹º¸°ÇÀǷῬ±¸¿ø-´ëÇÑÀÇÇÐȸ, ´ëÇÑ°¨¿°ÇÐȸ, ´ëÇÑ°áÇÙ ¹× È£Èí±âÇÐȸ, ´ëÇѼҾư¨¿°ÇÐȸ, ´ëÇÑ¿µ»óÀÇÇÐȸ, ´ëÇÑÀÀ±ÞÀÇÇÐȸ, ´ëÇÑÁßȯÀÚÀÇÇÐȸ, ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ

  • COVID-19 ȯÀÚ¿¡¼­ÀÇ ¼ö¼ú Áöħ (¿µ¹®)
    COVID-19 Áø·áÁöħ 2022
    COVID-19 ȯÀÚ¿¡¼­ÀÇ ¼ö¼ú Áöħ (¿µ¹®)

    ´ëÇÑ°¨¿°ÇÐȸ, ´ëÇÑÀÇ»çÇùȸ

  • Autoimmune Inflammatory Rheumatic Diseases ȯÀÚ¿¡¼­ COVID-19 Á¢Á¾ ±Ç°í¾È
    COVID-19 Áø·áÁöħ 2021
    Autoimmune Inflammatory Rheumatic Diseases ȯÀÚ¿¡¼­ COVID-19 Á¢Á¾ ±Ç°í¾È

    ´ëÇÑÀÇÇÐȸ

  • Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ-19 (COVID-19) ¾à¹° Ä¡·á¿¡ °üÇÑ ´ëÇÑ°¨¿°ÇÐȸ Áöħ(¿ä¾àº»)(version 2.0)(ÁßÁõµµ ºÐ·ù Ãß°¡)
    COVID-19 Áø·áÁöħ 2021
    Äڷγª¹ÙÀÌ·¯½º °¨¿°Áõ-19 (COVID-19) ¾à¹° Ä¡·á¿¡ °üÇÑ ´ëÇÑ°¨¿°ÇÐȸ Áöħ(¿ä¾àº»)(version 2.0)(ÁßÁõµµ ºÐ·ù Ãß°¡)

    ´ëÇÑ°¨¿°ÇÐȸ, ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ, ´ëÇѼҾư¨¿°ÇÐȸ

  • ´ëÇѳ»°úÇÐȸ Äڷγª19 ¹é½Å Á¢Á¾ ±Ç°í¾È
    COVID-19 Áø·áÁöħ 2021
    ´ëÇѳ»°úÇÐȸ Äڷγª19 ¹é½Å Á¢Á¾ ±Ç°í¾È

    ´ëÇѳ»°úÇÐȸ Ç¥ÁØÁø·áÁöħÀ§¿øȸ

  • ±¹³» »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º °¨¿°ÀÇ Áø´Ü ¹× Ä¡·á¿¡ °üÇÑ ÀÓ»óÁø·áÁöħ ±Ç°í¾È: 2021³â °³Á¤ÆÇ
    HIV Áø·áÁöħ 2021
    ±¹³» »ç¶÷¸é¿ª°áÇ̹ÙÀÌ·¯½º °¨¿°ÀÇ Áø´Ü ¹× Ä¡·á¿¡ °üÇÑ ÀÓ»óÁø·áÁöħ ±Ç°í¾È: 2021³â °³Á¤ÆÇ

    ´ëÇÑ¿¡ÀÌÁîÇÐȸ

  • Çѱ¹¿¡¼­ÀÇ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ Àû¿ë Áöħ
    Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ Áöħ 2021
    Çѱ¹¿¡¼­ÀÇ Ç×»ýÁ¦ ½ºÆ©¾îµå½Ê ÇÁ·Î±×·¥ Àû¿ë Áöħ

    ´ëÇÑ°¨¿°ÇÐȸ, ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ, Çѱ¹º´¿ø¾à»çȸ

  • ½ÅÁ¾Äڷγª¹ÙÀÌ·¯½º °Ë»ç¿¡ ´ëÇÑ ´ëÇÑ°¨¿°ÇÐȸ ±Ç°í¾È_20200211
    COVID-19 Áø·áÁöħ 2020
    ½ÅÁ¾Äڷγª¹ÙÀÌ·¯½º °Ë»ç¿¡ ´ëÇÑ ´ëÇÑ°¨¿°ÇÐȸ ±Ç°í¾È_20200211

    ´ëÇÑ°¨¿°ÇÐȸ

  • Äڷγª 19 (COVID-19) ¾à¹° Ä¡·á¿¡ °üÇÑ Àü¹®°¡ ±Ç°í¾È(key question)(version 1.1)
    COVID-19 Áø·áÁöħ 2020
    Äڷγª 19 (COVID-19) ¾à¹° Ä¡·á¿¡ °üÇÑ Àü¹®°¡ ±Ç°í¾È(key question)(version 1.1)

    ´ëÇÑ°¨¿°ÇÐȸ, ´ëÇÑÇ×±Õ¿ä¹ýÇÐȸ, ´ëÇѼҾư¨¿°ÇÐȸ, ´ëÇÑ°áÇÙ¹×È£Èí±âÇÐȸ